Document is current
Any future updates will be listed below
-
Authors
Cao, Jicong https://orcid.org/0000-0002-5253-3365
Novoa, Eva Maria
Zhang, Zhizhuo
Chen, William C. W.
Liu, Dianbo
Choi, Gigi C. G.
Wong, Alan S. L.
Wehrspaun, Claudia
Kellis, Manolis https://orcid.org/0000-0001-7113-9630
Lu, Timothy K. https://orcid.org/0000-0002-3918-8923
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health
United States Department of Defense | United States Army | U.S. Army Research, Development and Engineering Command | Army Research Office
- License Information
-
More Information
Article History
Received: 31 March 2020
Accepted: 14 June 2021
First Online: 6 July 2021
Competing interests
: J.C., E.M.N., Z.Z., M.K., and T.K.L. have filed patent applications on the work. The applicant is Massachusetts Institute of Technology. The application number:16/441,647. T.K.L. is a co-founder of Senti Biosciences, Synlogic, Engine Biosciences, Tango Therapeutics, Corvium, BiomX, Eligo Biosciences, Bota.Bio, and Avendesora. T.K.L. also holds financial interests in nest.bio, Ampliphi, IndieBio, MedicusTek, Quark Biosciences, Personal Genomics, Thryve, Lexent Bio, MitoLab, Vulcan, Serotiny, and Avendesora. The other authors declare no competing interests.
